**Figure 24.**

*Isabella's relative values of HbA1c BMI, INS/d show apparent glycemic control after the beginning of insulin therapy, currently, with INS/d 12 IU, that is, 30% of upper limit of its reference range. HbA1c decreased to nearly half of its previous concentration from period with insulin pen. There is also a slight decrease in BMI. This highlights the impact of swift implementation of MiniMed780G as well as continuous education on postinitial remission of insulin secretion.*

**Current goal:** to continue education, reduce HbA1c below 42 mmol/mol, management of hypoglycemia, and hyperlipoproteinemia; monitoring ketones (Galileo Glu/Ket).
